The cardiodynamic effects and mechanism of action of bretylium tosylate.
D000818:Animals; D001190:Arylsulfonates / Q000494:pharmacology; D001949:Bretylium Compounds / Q000008:administration & dosage / Q000494:pharmacology*; D004285:Dogs; D004837:Epinephrine / Q000008:administration & dosage / Q000494:pharmacology; D006321:Heart / Q000187:drug effects* / Q000502:physiology; D007263:Infusions, Parenteral; D009206:Myocardium / Q000378:metabolism; D010101:Oxygen Consumption; D011433:Propranolol / Q000008:administration & dosage / Q000494:pharmacology; D013268:Stimulation, Chemical; D014105:Tosyl Compounds / Q000008:administration & dosage
D001190:Arylsulfonates; D001949:Bretylium Compounds; D014105:Tosyl Compounds; D011433:Propranolol; D004837:Epinephrine